Vivanza Biosciences (BOM:530057) E10: ₹0.07 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530057 Vivanza Biosciences Ltd BOM:530057
51 GF Score
Price ₹1.75
GF Value ₹23.36
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Vivanza Biosciences E10?

Vivanza Biosciences BOM:530057 -0.57% 51 E10 is ₹0.07 as of Jun. 2026. GuruFocus rates BOM:530057 with a GF Score™ of 51/100 and a GF Value™ of ₹23.36 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vivanza Biosciences's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹0.040. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹0.07 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Vivanza Biosciences's average E10 Growth Rate was 250.00% per year. During the past 3 years, the average E10 Growth Rate was 35.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Vivanza Biosciences was 35.70% per year. The lowest was 35.70% per year. And the median was 35.70% per year.

As of today (2026-08-24), Vivanza Biosciences's current stock price is ₹1.75. Vivanza Biosciences's E10 for the quarter that ended in Jun. 2026 was ₹0.07. Vivanza Biosciences's Shiller PE Ratio of today is 25.00.

During the past 13 years, the highest Shiller PE Ratio of Vivanza Biosciences was 940.00. The lowest was 25.00. And the median was 120.50.


Vivanza Biosciences  (BOM:530057) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vivanza Biosciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1.75/0.07
=25.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Vivanza Biosciences was 940.00. The lowest was 25.00. And the median was 120.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vivanza Biosciences E10 Related Terms


Vivanza Biosciences E10 Historical Data

* Premium members only.

The historical data trend for Vivanza Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivanza Biosciences E10 Chart

Vivanza Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.12 0.02 0.03 0.01 0.05

Vivanza Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.04 0.05 0.05 0.07

BOM:530057 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivanza Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivanza Biosciences Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivanza Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vivanza Biosciences's Shiller PE Ratio falls into.


BOM:530057
51GF Score
Vivanza Biosciences Ltd BOM:530057
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivanza Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vivanza Biosciences's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.04/167.3573*167.3573
=0.040

Current CPI (Jun. 2026) = 167.3573.

Vivanza Biosciences Quarterly Data

per share eps CPI Adj_EPS
201609 -0.038 105.961 -0.060
201612 -0.078 105.196 -0.124
201703 0.032 105.196 0.051
201706 0.015 107.109 0.023
201709 0.005 109.021 0.008
201712 0.020 109.404 0.031
201803 0.011 109.786 0.017
201806 0.025 111.317 0.038
201809 -0.031 115.142 -0.045
201812 -0.066 115.142 -0.096
201903 -0.038 118.202 -0.054
201906 -0.054 120.880 -0.075
201909 -0.076 123.175 -0.103
201912 -0.041 126.235 -0.054
202003 0.122 124.705 0.164
202006 -0.042 127.000 -0.055
202009 0.052 130.118 0.067
202012 0.041 130.889 0.052
202103 -0.004 131.771 -0.005
202106 0.080 134.084 0.100
202109 0.065 135.847 0.080
202112 -0.012 138.161 -0.015
202203 -0.050 138.822 -0.060
202206 0.190 142.347 0.223
202209 0.420 144.661 0.486
202212 0.110 145.763 0.126
202303 -0.030 146.865 -0.034
202306 0.120 150.280 0.134
202309 0.070 151.492 0.077
202312 0.050 152.924 0.055
202403 -0.226 153.035 -0.247
202406 0.070 155.789 0.075
202409 0.000 157.882 0.000
202412 0.010 158.323 0.011
202503 -0.250 157.552 -0.266
202506 0.020 159.755 0.021
202509 0.140 162.289 0.144
202512 0.050 163.281 0.051
202603 -0.110 164.272 -0.112
202606 0.040 167.357 0.040

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹0.07 mean?
Vivanza Biosciences (BOM:530057) has a E10 of ₹0.07 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vivanza Biosciences and its competitors.
Is Vivanza Biosciences' E10 too high?
Vivanza Biosciences' current E10 is ₹0.07. Overall, Vivanza Biosciences has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vivanza Biosciences' E10 compare to ZTS?
Vivanza Biosciences' E10 of ₹0.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vivanza Biosciences and its competitors. Vivanza Biosciences's current E10 is ₹0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivanza Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Vivanza Biosciences (BOM:530057) is currently considered Possible Value Trap. The stock's GF Value™ is ₹23.36, compared to a current price of ₹1.75 — trading 92.5% below its estimated fair value. The current E10 is ₹0.07. Vivanza Biosciences' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Vivanza Biosciences (BOM:530057), the current E10 is ₹0.07 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivanza Biosciences (BOM:530057) Overvalued in 2026?

Based on GuruFocus' analysis, Vivanza Biosciences stock appears to be undervalued. The current stock price of ₹1.75 is trading 92.5% below its estimated GF Value™ of ₹23.36. GuruFocus considers Vivanza Biosciences to be Possible Value Trap.

Key valuation signals for BOM:530057:

  • E10: ₹0.07
  • GF Value™: ₹23.36 vs. price of ₹1.75 (92.5% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the BOM:530057 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivanza Biosciences Business Description

Address S.G. Highway, 403/TF, Sarthik II, Opposite Rajpath Club, Bodakdev, Ahmedabad, GJ, IND, 380054
Vivanza Biosciences Ltd is a pharmaceutical company. Its core focus areas include research and development, manufacturing, and the distribution of a wide range of pharma and pharmaceutical products. The company's product portfolio includes Medical examination gloves, Injections, Veterinary feeds, and others.
51GF Score

Get the complete analysis for BOM:530057

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.75
Price
₹23.36
GF Value